Back to Search
Start Over
Nebulized Nitroglycerin for Coronavirus Disease 2019–Associated Acute Respiratory Distress Syndrome: A Case Report
- Source :
- A&a Practice
- Publication Year :
- 2021
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2021.
-
Abstract
- We present a case where nitroglycerin tablets dissolved in saline and intravenous nitroglycerin solution were nebulized as surrogates for inhaled nitric oxide (iNO) after our iNO supply was depleted during the coronavirus disease 2019 (COVID-19) surge in New York. We gave this treatment to a COVID-19 patient with severe acute respiratory distress syndrome (ARDS) and hypercarbia. In response, the patient had immediate and clinically meaningful improvement in multiple organ systems despite no other interventions or ventilator changes.
- Subjects :
- Male
ARDS
Coronavirus disease 2019 (COVID-19)
Vasodilator Agents
medicine.medical_treatment
Case Report
Hypercarbia
Nitric oxide
Nitroglycerin
chemistry.chemical_compound
Pharmacotherapy
Humans
Medicine
Saline
Respiratory Distress Syndrome
business.industry
Nebulizers and Vaporizers
COVID-19
General Medicine
Middle Aged
medicine.disease
COVID-19 Drug Treatment
chemistry
Anesthesia
Etiology
business
medicine.drug
Subjects
Details
- ISSN :
- 25753126
- Volume :
- 15
- Database :
- OpenAIRE
- Journal :
- A&A Practice
- Accession number :
- edsair.doi.dedup.....fd37f10b413a7cd52cd5bda5bd2f97da